Efficacy News and Research

RSS
Emergent receives NIAID grant to advance development of MVA85A TB vaccine

Emergent receives NIAID grant to advance development of MVA85A TB vaccine

Antidepressants can play a key role in relieving pain associated with OA

Antidepressants can play a key role in relieving pain associated with OA

Alzheimer's may spread through connected neurons

Alzheimer's may spread through connected neurons

Thromboembolic events can occur after musculoskeletal injury and related surgery

Thromboembolic events can occur after musculoskeletal injury and related surgery

Urban children more likely to be smokers

Urban children more likely to be smokers

BHR Pharma enrolls first 400 patients for BHR-100 pivotal trial for TBI

BHR Pharma enrolls first 400 patients for BHR-100 pivotal trial for TBI

Cannabinoid drugs can directly inhibit HIV in late-stage AIDS

Cannabinoid drugs can directly inhibit HIV in late-stage AIDS

Bone-marrow derived MSCs may reduce acute rejection rates in kidney recipients

Bone-marrow derived MSCs may reduce acute rejection rates in kidney recipients

Enrollment complete in HAL Allergy PURETHAL Mites Phase II trial for allergic rhinitis/rhinoconjunctivitis

Enrollment complete in HAL Allergy PURETHAL Mites Phase II trial for allergic rhinitis/rhinoconjunctivitis

Thermedical closes $1.5 million in Series A funding

Thermedical closes $1.5 million in Series A funding

Noven completes LDMP Phase 3 studies on menopausal VMS

Noven completes LDMP Phase 3 studies on menopausal VMS

Cardium commences Generx Phase 3 registration study in myocardial ischemia

Cardium commences Generx Phase 3 registration study in myocardial ischemia

Positive data from Aerpio's AKB-9778 Phase 1 trial on DME

Positive data from Aerpio's AKB-9778 Phase 1 trial on DME

PROLOR commences hGH-CTP Phase II trial in children with GHD

PROLOR commences hGH-CTP Phase II trial in children with GHD

Acelrx fourth quarter net loss increases to $6.4 million

Acelrx fourth quarter net loss increases to $6.4 million

Ampio receives U.S. patent allowance for lead drug Ampion

Ampio receives U.S. patent allowance for lead drug Ampion

Study identifies risk factors for postpartum depressive symptoms

Study identifies risk factors for postpartum depressive symptoms

Positive data from XENTION's XEN-D0103 phase 1 trial on AF

Positive data from XENTION's XEN-D0103 phase 1 trial on AF

New antibiotic shows promise against bovine mastitis

New antibiotic shows promise against bovine mastitis

AstraZeneca, Targacept announce top-line results from remaining TC-5214 Phase 3 studies on MDD

AstraZeneca, Targacept announce top-line results from remaining TC-5214 Phase 3 studies on MDD

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.